|
|
|
|
| LEADER |
02605nmm a2200301 u 4500 |
| 001 |
EB000945331 |
| 003 |
EBX01000000000000000738921 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
150302 ||| eng |
| 020 |
|
|
|a 9783319131504
|
| 100 |
1 |
|
|a Evens, Andrew M.
|e [editor]
|
| 245 |
0 |
0 |
|a Non-Hodgkin Lymphoma
|h Elektronische Ressource
|b Pathology, Imaging, and Current Therapy
|c edited by Andrew M. Evens, Kristie A. Blum
|
| 250 |
|
|
|a 1st ed. 2015
|
| 260 |
|
|
|a Cham
|b Springer International Publishing
|c 2015, 2015
|
| 300 |
|
|
|a VI, 344 p. 35 illus., 25 illus. in color
|b online resource
|
| 505 |
0 |
|
|a Allogeneic Hematopoietic Cell Transplantation in Non-Hodgkin’s Lymphomas -- Management of Diffuse Large B-cell Lymphoma -- Epidemiology and Etiology of Non-Hodgkin Lymphoma -- Current Therapeutic Strategies and New Treatment Paradigms for Follicular Lymphoma -- Gene Expression Profiling in Non-Hodgkin lymphomas -- Management of the Marginal Zone Lymphomas -- Treatment Strategies in Mantle Cell Lymphoma -- Pathology of B-cell Lymphomas: Diagnosis and Biomarker Discovery -- Pathology of T-cell lymphomas: Diagnosis and Biomarker Discovery -- Imaging of non-Hodgkin lymphomas: Diagnosis and Response-Adapted Strategies -- Current Management of Peripheral T-cell lymphomas -- Post Transplant Lymphoproliferative Disorders -- Biology, Prognosis and Therapy of Waldenström Macroglobulinemia -- Prognosis and Therapy of Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
|
| 653 |
|
|
|a Hematology
|
| 653 |
|
|
|a Oncology
|
| 653 |
|
|
|a Pathology
|
| 700 |
1 |
|
|a Blum, Kristie A.
|e [editor]
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b Springer
|a Springer eBooks 2005-
|
| 490 |
0 |
|
|a Cancer Treatment and Research
|
| 028 |
5 |
0 |
|a 10.1007/978-3-319-13150-4
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-319-13150-4?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 616.994
|
| 520 |
|
|
|a This book provides clinical practitioners and the research community with detailed information on the diagnosis, prognosis, and treatment of non-Hodgkin lymphoma, taking into account the significant growth in knowledge including multiple therapeutic advances that have been achieved over the past 5-10 years. The work is subdivided into epidemiology, pathogenesis, pathology, imaging, and therapy of the non-Hodgkin lymphomas. The full range of therapeutic options are examined according to the major subtypes of non-Hodgkin lymphoma and the most up-to-date information is provided on current standard treatment options, including stem cell transplantation as well as new cutting-edge therapeutics
|